CD34 and acute myeloid leukemia: It is also documented that glutamine levels control OXPHOS in AML cells and glutaminolysis inhibitors activate mitochondrial apoptosis, whereas in normal CD34+ hematopoietic progenitors, glutaminase isoform 1 (GLS1) inhibition does not result in reduced proliferation and/or survival of these cells [23,24].